Skip to content

A study of a non-invasive measurement method for idiopathic pulmonary fibrosis patients. The predictive value of the IOS for the degree of fibrosis compared to the lung function test.

A study of a non-invasive measurement method for idiopathic pulmonary fibrosis patients. The predictive value of the IOS for the degree of fibrosis compared to the lung function test. - IOS IPF study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55805
Enrollment
120
Registered
2019-04-04
Start date
2021-01-04
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic pulmonary fibrosis

Interventions

None listed

Sponsors

Martini Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Diagnosed UIP based on the HRCT (UIP pattern or consistency UIP) with fibrosis score> 4 point. Age 18 and older

Exclusion criteria

Exclusion criteria: Other ILD / pulmonary fibrosis, lung carcinoma and other systemic diseases. Patients who can not well perform pumonary function test.

Design outcomes

Primary

MeasureTime frame
Primary Objectives: 1. Does IOS correlate with the degree of fibrosis on the HRCT scan in patients with IPF? - Which IOS parameter correlates best with the degree of fibrosis?

Secondary

MeasureTime frame
Secondary Objectives: 1. Is IOS as suitable as the CPI (= conventional spirometry + diffusion) to determine the degree of fibrosis in patients with IPF? - Correlation CPI / HRCT vs correlation IOS / HRCT (comparable or IOS better?) - Our correlation CPI / HRCT corresponding to the r = 0.71 obtained from Wells et al. 2. Does exercise effects the IOS measurement? - IOS before and after conventional lung functions tests. 3. How does the patient experience the IOS measurement? - BORG score + questionnaire

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)